Annual CFI
-$87.18 M
-$86.98 M-43709.05%
December 31, 2023
Summary
- As of February 7, 2025, SPRY annual cash flow from investing activities is -$87.18 million, with the most recent change of -$86.98 million (-43709.05%) on December 31, 2023.
- During the last 3 years, SPRY annual CFI has fallen by -$87.18 million (-100.00%).
Performance
SPRY Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$16.82 M
+$29.46 M+232.99%
September 30, 2024
Summary
- As of February 7, 2025, SPRY quarterly cash flow from investing activities is $16.82 million, with the most recent change of +$29.46 million (+232.99%) on September 30, 2024.
- Over the past year, SPRY quarterly CFI has increased by +$29.46 million (+232.99%).
- SPRY quarterly CFI is now -62.60% below its all-time high of $44.97 million, reached on June 30, 2023.
Performance
SPRY Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$21.70 M
+$63.46 M+151.96%
September 30, 2024
Summary
- As of February 7, 2025, SPRY TTM cash flow from investing activities is $21.70 million, with the most recent change of +$63.46 million (+151.96%) on September 30, 2024.
- Over the past year, SPRY TTM CFI has increased by +$63.46 million (+151.96%).
- SPRY TTM CFI is now at all-time high.
Performance
SPRY TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SPRY Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10000.0% | +233.0% | +152.0% |
| 3 y3 years | -100.0% | +233.0% | +152.0% |
| 5 y5 years | -100.0% | +233.0% | +152.0% |
SPRY Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | -62.6% | +115.1% | at high | +119.1% |
| 5 y | 5-year | <-9999.0% | at low | -62.6% | +115.1% | at high | +119.1% |
| alltime | all time | <-9999.0% | at low | -62.6% | +115.1% | at high | +119.1% |
ARS Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $16.82 M(-233.0%) | $21.70 M(-152.0%) |
| Jun 2024 | - | -$12.65 M(+48.5%) | -$41.76 M(-363.4%) |
| Mar 2024 | - | -$8.51 M(-132.7%) | $15.85 M(-118.2%) |
| Dec 2023 | -$87.18 M | $26.04 M(-155.8%) | -$87.18 M(-23.1%) |
| Sep 2023 | - | -$46.64 M(-203.7%) | -$113.34 M(+69.9%) |
| Jun 2023 | - | $44.97 M(-140.3%) | -$66.73 M(-40.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$111.55 M(>+9900.0%) | -$111.72 M(>+9900.0%) |
| Dec 2022 | -$199.00 K(+261.8%) | -$126.00 K(+320.0%) | -$199.00 K(+172.6%) |
| Sep 2022 | - | -$30.00 K(+36.4%) | -$73.00 K(+69.8%) |
| Jun 2022 | - | -$22.00 K(+4.8%) | -$43.00 K(+104.8%) |
| Mar 2022 | - | -$21.00 K | -$21.00 K |
| Dec 2021 | -$55.00 K(<-9900.0%) | - | - |
| Dec 2020 | $0.00 | - | - |
FAQ
- What is ARS Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual CFI year-on-year change?
- What is ARS Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly CFI year-on-year change?
- What is ARS Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals TTM CFI year-on-year change?
What is ARS Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of SPRY is -$87.18 M
What is the all time high annual CFI for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual cash flow from investing activities is $0.00
What is ARS Pharmaceuticals annual CFI year-on-year change?
Over the past year, SPRY annual cash flow from investing activities has changed by -$86.98 M (-43709.05%)
What is ARS Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of SPRY is $16.82 M
What is the all time high quarterly CFI for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly cash flow from investing activities is $44.97 M
What is ARS Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, SPRY quarterly cash flow from investing activities has changed by +$29.46 M (+232.99%)
What is ARS Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of SPRY is $21.70 M
What is the all time high TTM CFI for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high TTM cash flow from investing activities is $21.70 M
What is ARS Pharmaceuticals TTM CFI year-on-year change?
Over the past year, SPRY TTM cash flow from investing activities has changed by +$63.46 M (+151.96%)